← Back to Search

Spinal Implant

Synergy Disc vs. ACDF Surgery for Degenerative Disc Disease

N/A
Recruiting
Research Sponsored by Synergy Spine Solutions
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 week, 3 month, 6 month, 12 month, 24 month
Awards & highlights

Study Summary

This trial will compare the safety and effectiveness of Synergy Disc to traditional ACDF for treating cervical DDD in unresponsive patients. Results evaluated before & after surgery, & at 3, 6, 12 & 24 months. Primary analysis at 24 months.

Who is the study for?
This trial is for adults over 18 with neck pain and cervical degenerative disc disease at two adjacent levels from C3 to C7, who haven't improved with non-surgical treatments. They must have a specific level of disability and pain, documented nerve compression, no severe facet joint issues or certain metabolic disorders, no recent investigational therapy or spinal surgeries (with some exceptions), not be pregnant or planning pregnancy during the study.Check my eligibility
What is being tested?
The study is testing the Synergy Disc's safety and effectiveness compared to conventional anterior cervical discectomy and fusion (ACDF) surgery in treating cervical degenerative disc disease. Patients will be monitored before surgery and up to 24 months post-surgery to see if this new treatment works as well as the standard one.See study design
What are the potential side effects?
While side effects are not explicitly listed here, typical risks associated with spine surgery may include infection, nerve damage, blood clots, reactions to anesthesia, implant failure or movement, persistent pain at the bone graft site (for ACDF), difficulty swallowing or hoarseness.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 week, 3 month, 6 month, 12 month, 24 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 week, 3 month, 6 month, 12 month, 24 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Device Related Adverse Event
NDI
Secondary Surgical Intervention
+1 more
Secondary outcome measures
BZ Score
Odom's Criteria
Patient Satisfaction
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Synergy DiscExperimental Treatment1 Intervention
The Synergy Disc is a cervical disc prosthesis that can be inserted between C3-C7 in skeletally mature patients after anterior discectomy to provide restoration of motion to the functional spinal unit. The Synergy Disc is designed to restore kinematics to the cervical spine. The Synergy Disc is intended for use in the cervical spine for reconstruction of the disc following a two level discectomy for intractable radiculopathy and/or myelopathy.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Anterior Cervical Discectomy and Fusion
2006
Completed Phase 3
~340

Find a Location

Who is running the clinical trial?

Synergy Spine SolutionsLead Sponsor
6 Previous Clinical Trials
575 Total Patients Enrolled
MCRAIndustry Sponsor
33 Previous Clinical Trials
9,166 Total Patients Enrolled
Jane M Jacob, PhDStudy DirectorSynergy Spine Solutions
3 Previous Clinical Trials
300 Total Patients Enrolled

Media Library

Synergy Disc (Spinal Implant) Clinical Trial Eligibility Overview. Trial Name: NCT05740176 — N/A
Cervical Disc Degeneration Research Study Groups: Synergy Disc
Cervical Disc Degeneration Clinical Trial 2023: Synergy Disc Highlights & Side Effects. Trial Name: NCT05740176 — N/A
Synergy Disc (Spinal Implant) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05740176 — N/A
~100 spots leftby Jun 2025